Head to Head Comparison: Medtronic (NYSE:MDT) & QT Imaging (NASDAQ:QTI)

Medtronic (NYSE:MDT) and QT Imaging (NASDAQ:QTI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, valuation, earnings, profitability and institutional ownership.

Volatility and Risk

Medtronic has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500.

Profitability

This table compares Medtronic and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medtronic	13.00%	13.79%	7.62%
QT Imaging	N/A	N/A	-65.94%

Insider and Institutional Ownership

82.1% of Medtronic shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 0.2% of Medtronic shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Medtronic and QT Imaging”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medtronic	$32.36 billion	3.69	$3.68 billion	$3.27	28.45
QT Imaging	$4.00 million	2.25	-$4.03 million	N/A	N/A

Medtronic has higher revenue and earnings than QT Imaging.

Analyst Recommendations

This is a breakdown of current ratings for Medtronic and QT Imaging, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medtronic	1	9	6	1	2.41
QT Imaging	0	0	0	0	0.00

Medtronic presently has a consensus target price of $95.00, indicating a potential upside of 2.13%. Given Medtronic’s stronger consensus rating and higher possible upside, analysts plainly believe Medtronic is more favorable than QT Imaging.

Summary

Medtronic beats QT Imaging on 12 of the 13 factors compared between the two stocks.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.